Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

H.R.3 - Lower Drug Costs Now Act of 2019 S.977 - Transparent Drug Pricing Act of 2019 S.551, REFUND Act of 2019 H.R. 1520, the Purple Book Continuity Act H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act H.R. 965, the CREATES Act H.R.269/S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. S. 3013, Encouraging Innovative Benefit Design to Lowes Costs for Seniors Act S. 3129, Lower Cost, More Cures Act of 2019 H.R. 2296 - More Efficient Tools to Realize Information for Consumers Act H.R. 5741- Strengthening Innovation in Medicare and Medicaid Act - Issues related to Medicare and Medicaid coverage and reimbursement - Issues related to the 340B Drug Discount Program - Issues related to drug pricing - Medicare reimbursement for biosimilars - MACRA treatment and reimbursement of Part B drugs - Medicare payments for inpatient antimicrobials - Issues related to drug importation - Issues related to the International Pricing Index for Medicare Part B - Issues related to CMMI

Client expense: $2,020,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021, H.R. 925 Updated Heroes Act, H.R.8496 SPEEDY COVID-19 Tests Act, S.4198 Affordable Coronavirus Testing Act, S.4740 Public Health Infrastructure Saves Lives Act, H.R.8505 To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes., H.R.8702 Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021, H.R. 925 Updated Heroes Act, H.R.8496 SPEEDY COVID-19 Tests Act, S.4198 Affordable Coronavirus Testing Act, S.4740 Public Health Infrastructure Saves Lives Act, H.R.8505 To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes., H.R.8702 Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises; H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021, H.R. 925 Updated Heroes Act, H.R.8496 SPEEDY COVID-19 Tests Act, S.4198 Affordable Coronavirus Testing Act, S.4740 Public Health Infrastructure Saves Lives Act, H.R.8505 To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes., H.R.8702 Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR3502 Protecting People From Surprise Medical Bills Act H.R. 3630: To amend title XXVII of the Public Health Service Act HR. 1384: Medicare for All Act of 2019 H.R. 861: End Surprise Billing Act of 2019 S. 1266: Protecting Patients from Surprise Medical Bills Act S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 H.R. 345: SMASH Act S. 1213: Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patients VALID - Verifying Accurate Leading Edge IVCT Development Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S348, HR 1763

Client expense: $183,583 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1423 / S. 610 - Forced Arbitration Injustice Repeal (FAIR) Act - oppose H.R. 5216 / S. 2943 - Quality Care for Nursing Home Residents Act - oppose H.R. 5326 - Fairness in Nursing Home Arbitration Act - oppose H.R. 2749 / S. 1491 - Restoring Justice for Workers Act - oppose S. 630 - Arbitration Fairness for Consumers Act - oppose S. 620 - Safety Over Arbitration Act - oppose S. 2627 - End Double Taxation of Successful Civil Claims Act- oppose H.R. 4982 - Health Care Workforce Protection Act - support H.R. 269 / S. 1379 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Pub. Law No. 116-22) - support S. 766 - PROTECT Asbestos Victims Act - support S. 471 - Litigation Funding Transparency Act - support H.R. 7059, Coronavirus Provider Protection Act - support H.R. 6021, Families First Coronavirus Response Act - support H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) - support

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 3.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 4.Implementation of Every Student Succeeds Act (Public Law 114-95) 5.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 6.Midnight Rules Relief Act (S.34/H.R. 21) 7.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 8.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 9.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 10.Regulatory Integrity Act (H.R. 1004) 11.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 12.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 13.American Health Care Act (H.R. 1628/H.Res. 228) 14.Ozone Standards Implementation Act (S. 263/H.R. 806) 15.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 16.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 17.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 18.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 19.Preventing Antibiotic Resistance Act (S. 629) 20.Better Care Reconciliation Act (H.R. 1628) and related amendments 21.Public Health Emergency Response Act (S. 196) 22.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 23.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 24.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 25.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 26.Tobacco Tax Equity Act (S. 1837) 27.Healthy Kids Act (S. 1821/H.R. 3921) 28.Implementation of the Drug Quality and Security Act (P.S. 113-54) 29.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 30.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 31.Lead-Safe Housing for Kids Act (S. 1845) 32.Supporting Working Moms Act (S. 2122/H.R. 3255) 33.Championing Healthy Kids Act (H.R. 3922) 34.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 35.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 36.Tax Cuts and Jobs Act (Public Law 115-97) 37.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 38.Vaccine Access Improvement Act (H.R. 4993) 39.Relief from New Source Performance Standards Act (H.R. 453) 40.Strategies to Address Antimicrobial Resistance (S. 2469) 41.Opioid Quota Reform Act (S. 2535) 42.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 43.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 44.Opioid Crisis Response Act of 2018 (S. 2680) 45.Agriculture and Nutrition Act (H.R. 2) 46.Agriculture Improvement Act (S. 3042) 47.SECURE Act (H.R. 5998) 48.Trauma-Informed Care for Children and Families Act (S. 774) 49.SUPPORT for Patients and Communities Act (H.R. 6) 50.Centers for Disease Control Emergency Response Act (S. 3161) 51.LABEL Opioids Act (S. 3428) 52.Relief from New Source Performance Standards Act (S. 1857) 53.Outdoors for All Act (S. 3499) 54.The MOMMA Act (H.R. 5977) 55.Preventing Maternal Deaths Act (H.R. 1318) 56.Medicare Access to Vaccines Equity Act (not yet introduced) 57.The Support Act (H.R. 6) 58.Climate Change Health Protection and Promotion Act (S. 529) 59.NURSE Act (H.R. 1597) 60.Investing for the People Act (H.R. 2021) 61.Child Care for Working Families Act (H.R. 365/S. 568) 62.FAMILY Act (H.R. 1185/S. 463) 63.Transportation Alternatives Enhancement Act (S. 1098) 64.Lower Health Care Costs Act (S. 1895) 65.LIFT America Act (H.R 2479) 66.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 67.Supporting Older Americans Act of 2020 (HR 4334) 68.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 69.Healthier Students for Stronger Campuses Act (S. 1281) 70.Saving Lives Through Better Data Act (S. 1793) 71.VACCINES Act (H.R. 2862) 72.DISARM Act (H.R. 4100/S. 1712) 73.Community Access, Resources, and Education for Families Act (H.R. 3117) 74.Protecting Seniors Through Immunization Act (S. 1872) 75.Tobacco-Free Youth Act (S. 1541) 76.Tobacco to 21 Act (H.R. 2411/S. 1258) 77.Investing for People Act (H.R. 2021) 78.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 79.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) 80.Social Determinants Accelerator Act (H.R. 4004/S. 2986) 81.Mental Health Professionals Workforce Shortage Loan Repayment Act (H.R. 2431) 82.The UNDERSTAND Act (S. 1323) 83.Americas Transportation Infrastructure Act (S. 2302) 84.Barriers to Suicide Act of 2019 (H.R. 4309) 85.Promoting Physical Activity for Americans Act (S. 1608/H.R. 2891) 86.Public Health Infrastructure Modernization Act of 2019 (H.R. 5321) 87.Supporting Healthy Mothers and Infants Act (H.R. 5249) 88.Lead-Free Future Act (H.R. 4416) 89.Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R. 4768) 90.Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide (H. Res. 592) 91.Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) 92.Families First Coronavirus Response Act (H.R. 6201) 93.Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748) 94.Connecting Americas Transportation Infrastructure Act (H.R. 5696/S. 3391)) 95.Improving Access to Remote Behavioral Health Treatment Act (S. 2244/H.R. 4131) 96.National Suicide Hotline Designation Act (S. 2661/H.R. 4194) 97.Suicide Prevention Lifeline Improvement Act (H.R. 4564) 98.Campaign to Prevent Suicide Act (H.R. 4585) 99.Medicaid Reentry Act (H.R. 1329) 100.Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767) 101.Mental Health Services for Students Act (S. 1122/H.R. 1109) 102.Suicide Training and Awareness Nationally Delivered for Universal Prevention (STANDUP) Act (S. 2492/H.R. 2599) 103.Mental Health Parity Compliance Act (S. 1737/H.R. 3165) 104.Behavioral Health Transparency Act (S. 1576/H.R. 2874) 105.Medicare Mental Health Access Act (S. 2772/H.R. 884) 106.Public Health Emergency Response and Accountability Act (S. 3309) 107.Family Violence Prevention and Services Improvement Act (H.R. 5041) 108.Protecting the Health of Americas Older Adults During COVID-19 and Beyond Act (H.R. 6935) 109.Improving Social Determinants Act (H.R. 6561/S. 4440) 110.Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H.Con.Res.100) 111.FY 2021 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (TBD) 112.Better Tools for Healthy Living Act (S. 1805) 113.The WIC Act (H.R. 6811/S. 2358) 114.Health Equity and Accountability Act (H.R. 6637) 115.Paycheck Protection Program and Health Care Enhancement Act (H.R. 266) 116.The HEROES Act (H.R.6800) 117.Community Solutions for COVID-19 Act (H.R.7077/S.3877) 118.The Black Maternal Health Momnibus Act of 2020 (H.R. 6142) 119.COVID-19 Bias and Anti-Racism Training Act (H.R. 7618/S. 4248) 120.Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H. Con. Res. 100) 121.Community Immunity During COVID-19 Act of 2020 (H.R. 8061) 122.Public Safety Officer Support Act (H.R. 7568) 123.COVID-19 Behavioral Health Support Act (S. 4059) 124.Public Health Workforce Loan Repayment Act (H.R. 6578) 125.Strengthening the Public Health Workforce Act (S. 3737) 126.A resolution declaring racism a public health crisis (S. Res. 655) 127.Pandemic Child Hunger Prevention Act (H.R.7887) 128.Public Health Infrastructure Saves Lives Act (S. 4740) 129.CARE for Families Act (H.R. 3117/S. 3354) 130.Improving Data Collection for Adverse Childhood Experiences Act (H.R. 7689) 131.The STANDUP Act of 2020 (H.R. 7293) 132.The Effective Suicide Screening and Assessment in the Emergency Department Act (H.R. 4861) 133.The Pursuing Equity in Mental Health Act of 2019 (H.R. 5469) 134.The Improving Mental Health Access from the Emergency Department Act (H.R. 2519/S. 1334) 135.The Suicide Prevention Act (H.R. 5619/S. 3198) 136.The Helping Emergency Responders Overcome (HERO) Act (H.R. 1646/S. 3244) 137.The Campaign to Prevent Suicide Act (H.R. 4585) 138.The Maternal Health Immunization Enhancement Act (S. 4690) 139.Pandemic Vaccine Access Improvement Act (Not yet introduced) 140.Moving Forward Act (H.R. 2) 141.Continuing Appropriations Act, 2021 and Other Extensions Act (HR 8319) Coronavirus Response Additional Supplemental Appropriations Act (S. 4320). 142.ETHIC Act (H.R. 8205) 143.Safely Back to School and Work Act (S. 4322) 144.Supporting the goals and ideals of BIPOC Mental Health Awareness Month (H.Res. 1064) 145.COVID-19 Health Disparities Action Act (S. 4262) 146.Protecting American Heroes Act of 2020 (S. 4368) 147.Health STATISTICS Act (H.R. 8080) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, NIMH, Education, USDA, DHS, FEMA, and SAMHSA.

Client expense: $36,974 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act.

Client expense: $454,390 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises; H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act.

Client expense: $454,390 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act.

Client expense: $454,390 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act.

Client expense: $454,390 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR3502 Protecting People From Surprise Medical Bills Act H.R. 3630: To amend title XXVII of the Public Health Service Act HR. 1384: Medicare for All Act of 2019 H.R. 861: End Surprise Billing Act of 2019 S. 1266: Protecting Patients from Surprise Medical Bills Act S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 H.R. 345: SMASH Act S. 1213: Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patients VALID - Verifying Accurate Leading Edge IVCT Development Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S348, HR 1763

Client expense: $134,437 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3 - Lower Drug Costs Now Act of 2019 S.977 - Transparent Drug Pricing Act of 2019 S.551, REFUND Act of 2019 H.R. 1520, the Purple Book Continuity Act H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act H.R. 965, the CREATES Act H.R.269/S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. S. 3013, Encouraging Innovative Benefit Design to Lowes Costs for Seniors Act S. 3129, Lower Cost, More Cures Act of 2019 H.R. 2296 - More Efficient Tools to Realize Information for Consumers Act H.R. 5741- Strengthening Innovation in Medicare and Medicaid Act -Issues related to Medicare and Medicaid coverage and reimbursement -Issues related to the 340B Drug Discount Program -Issues related to drug pricing -Medicare reimbursement for biosimilars -MACRA treatment and reimbursement of Part B drugs -Medicare payments for inpatient antimicrobials -Issues related to drug importation -Issues related to the International Pricing Index for Medicare Part B -Issues related to CMMI

Client expense: $2,710,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2. Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 3. Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111- 296) 4. Implementation of Every Student Succeeds Act (Public Law 114-95) 5. Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 6. Midnight Rules Relief Act (S.34/H.R. 21) 7. Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 8. Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 9. Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 10. Regulatory Integrity Act (H.R. 1004) 11. OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 12. A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 13. American Health Care Act (H.R. 1628/H.Res. 228) 14. Ozone Standards Implementation Act (S. 263/H.R. 806) 15. Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 16. Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 17. Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 18. Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 19. Preventing Antibiotic Resistance Act (S. 629) 20. Better Care Reconciliation Act (H.R. 1628) and related amendments 21. Public Health Emergency Response Act (S. 196) 22. Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 23. Treat and Reduce Obesity Act (S. 830/H.R. 1953) 24. Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 25. Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 26. Tobacco Tax Equity Act (S. 1837) 27. Healthy Kids Act (S. 1821/H.R. 3921) 28. Implementation of the Drug Quality and Security Act (P.S. 113-54) 29. Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 30. Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 31. Lead-Safe Housing for Kids Act (S. 1845) 32. Supporting Working Moms Act (S. 2122/H.R. 3255) 33. Championing Healthy Kids Act (H.R. 3922) 34. Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 35. An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115- 96) 36. Tax Cuts and Jobs Act (Public Law 115-97) 37. Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 38. Vaccine Access Improvement Act (H.R. 4993) 39. Relief from New Source Performance Standards Act (H.R. 453) 40. Strategies to Address Antimicrobial Resistance (S. 2469) 41. Opioid Quota Reform Act (S. 2535) 42. Hospital Preparedness Program Reauthorization Act (H.R. 4776) 43. Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 44. Opioid Crisis Response Act of 2018 (S. 2680) 45. Agriculture and Nutrition Act (H.R. 2) 46. Agriculture Improvement Act (S. 3042) 47. SECURE Act (H.R. 5998) 48. Trauma-Informed Care for Children and Families Act (S. 774) 49. SUPPORT for Patients and Communities Act (H.R. 6) 50. Centers for Disease Control Emergency Response Act (S. 3161) 51. LABEL Opioids Act (S. 3428) 52. Relief from New Source Performance Standards Act (S. 1857) 53. Outdoors for All Act (S. 3499) 54. The MOMMA Act (H.R. 5977) 55. Preventing Maternal Deaths Act (H.R. 1318) 56. Medicare Access to Vaccines Equity Act (not yet introduced) 57. The Support Act (H.R. 6) 58. Climate Change Health Protection and Promotion Act (S. 529) 59. NURSE Act (H.R. 1597) 60. Investing for the People Act (H.R. 2021) 61. Child Care for Working Families Act (H.R. 365/S. 568) 62. FAMILY Act (H.R. 1185/S. 463) 63. Transportation Alternatives Enhancement Act (S. 1098) 64. Lower Health Care Costs Act (S. 1895) 65. LIFT America Act (H.R 2479) 66. Public Health Funding Restoration Act (H.R. 3447/S. 1944) 67. Supporting Older Americans Act of 2020 (HR 4334) 68. Campus Prevention and Recovery Services for Students Act (H.R. 3591) 69. Healthier Students for Stronger Campuses Act (S. 1281) 70. Saving Lives Through Better Data Act (S. 1793) 71. VACCINES Act (H.R. 2862) 72. DISARM Act (H.R. 4100/S. 1712) 73. Community Access, Resources, and Education for Families Act (H.R. 3117) 74. Protecting Seniors Through Immunization Act (S. 1872) 75. Tobacco-Free Youth Act (S. 1541) 76. Tobacco to 21 Act (H.R. 2411/S. 1258) 77. Investing for People Act (H.R. 2021) 78. School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 79. Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) 80. Social Determinants Accelerator Act (H.R. 4004) 81. Mental Health Professionals Workforce Shortage Loan Repayment Act (H.R. 2431) 82. The UNDERSTAND Act (S. 1323) 83. Americas Transportation Infrastructure Act (S. 2302) 84. Barriers to Suicide Act of 2019 (H.R. 4309) 85. Promoting Physical Activity for Americans Act (S. 1608/H.R. 2891) 86. Public Health Infrastructure Modernization Act of 2019 (H.R. 5321) 87. Supporting Healthy Mothers and Infants Act (H.R. 5249) 88. Lead-Free Future Act (H.R. 4416) 89. Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R. 4768) 90. Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide (H. Res. 592) 91. Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) 92. Families First Coronavirus Response Act (H.R. 6201) 93. Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748) 94. Connecting Americas Transportation Infrastructure Act (S. 2302) 95. Improving Access to Remote Behavioral Health Treatment Act (S. 2244/H.R. 4131) 96. National Suicide Hotline Designation Act (S. 2661/H.R. 4194) 97. Suicide Prevention Lifeline Improvement Act (H.R. 4564) 98. Campaign to Prevent Suicide Act (H.R. 4585) 99. Medicaid Reentry Act (H.R. 1329) 100. Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767) 101. Mental Health Services for Students Act (S. 1122/H.R. 1109) 102. Suicide Training and Awareness Nationally Delivered for Universal Prevention (STANDUP) Act (S. 2492/H.R. 2599) 103. Mental Health Parity Compliance Act (S. 1737/H.R. 3165) 104. Behavioral Health Transparency Act (S. 1576/H.R. 2874) 105. Medicare Mental Health Access Act (S. 2772/H.R. 884) 106. Public Health Emergency Response and Accountability Act (S. 3309) 107. Family Violence Prevention and Services Improvement Act (H.R. 5041) 108. Protecting the Health of Americas Older Adults During COVID-19 and Beyond Act (H.R. 6935) 109. Improving Social Determinants Act (H.R. 6561) 110. Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H.Con.Res.100) 111. FY 2021 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (TBD) 112. Better Tools for Healthy Living Act (S. 1805) 113. The WIC Act (S. 2358) 114. Health Equity and Accountability Act (H.R. 6637) 115. Paycheck Protection Program and Health Care Enhancement Act (H.R. 266) 116. The HEROES Act (H.R.6800) 117. Community Solutions for COVID-19 Act (H.R.7077/S.3877) 118. The Black Maternal Health Momnibus Act of 2020 (H.R. 6142) 119. COVID-19 Bias and Anti-Racism Training Act (S.___) 120. Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H. Con. Res. 100) 121. Community Immunity During COVID-19 Act of 2020 (H.R._____) 122. Public Safety Officer Support Act (H.R. 7568) 123. COVID-19 Behavioral Health Support Act (S. 4059) 124. Public Health Workforce Loan Repayment Act (H.R. 6578) 125. Strengthening the Public Health Workforce Act (S. 3737) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, NIMH, Education, USDA, DHS, FEMA, and SAMHSA

Client expense: $32,208 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)

H.R.3 - Lower Drug Costs Now Act of 2019 S.977 - Transparent Drug Pricing Act of 2019 S.551, REFUND Act of 2019 H.R. 1520, the Purple Book Continuity Act H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act H.R. 965, the CREATES Act H.R.269/S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. S. 3013, Encouraging Innovative Benefit Design to Lowes Costs for Seniors Act S. 3129, Lower Cost, More Cures Act of 2019 H.R. 2296 - More Efficient Tools to Realize Information for Consumers Act H.R. 5741- Strengthening Innovation in Medicare and Medicaid Act - Issues related to Medicare and Medicaid coverage and reimbursement - Issues related to the 340B Drug Discount Program - Issues related to drug pricing - Medicare reimbursement for biosimilars - MACRA treatment and reimbursement of Part B drugs - Medicare payments for inpatient antimicrobials - Issues related to drug importation - Issues related to the International Pricing Index for Medicare Part B - Issues related to CMMI

Client expense: $1,910,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021.

Client expense: $599,857 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Vice President of the U.S., White House Office

commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises; H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021.

Client expense: $599,857 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Vice President of the U.S., White House Office

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021.

Client expense: $599,857 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Vice President of the U.S., White House Office

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021.

Client expense: $599,857 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Vice President of the U.S., White House Office

HR3502 Protecting People From Surprise Medical Bills Act H.R. 3630: To amend title XXVII of the Public Health Service Act HR. 1384: Medicare for All Act of 2019 H.R. 861: End Surprise Billing Act of 2019 S. 1266: Protecting Patients from Surprise Medical Bills Act S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 H.R. 345: SMASH Act S. 1213: Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patients VALID - Verifying Accurate Leading Edge IVCT Development Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S348, HR 1763

Client expense: $195,130 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1423 / S. 610 - Forced Arbitration Injustice Repeal (FAIR) Act - oppose H.R. 5216 / S. 2943 - Quality Care for Nursing Home Residents Act - oppose H.R. 5326 - Fairness in Nursing Home Arbitration Act - oppose H.R. 2749 / S. 1491 - Restoring Justice for Workers Act - oppose S. 630 - Arbitration Fairness for Consumers Act - oppose S. 620 - Safety Over Arbitration Act - oppose S. 2627 - End Double Taxation of Successful Civil Claims Act- oppose H.R. 4982 - Health Care Workforce Protection Act - support H.R. 269 / S. 1379 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Pub. Law No. 116-22) - support S. 766 - PROTECT Asbestos Victims Act - support S. 471 - Litigation Funding Transparency Act - support H.R. 7059, Coronavirus Provider Protection Act - support H.R. 6021, Families First Coronavirus Response Act - support H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) - support

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR3502 Protecting People From Surprise Medical Bills Act H.R. 3630: To amend title XXVII of the Public Health Service Act HR. 1384: Medicare for All Act of 2019 H.R. 861: End Surprise Billing Act of 2019 S. 1266: Protecting Patients from Surprise Medical Bills Act S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 H.R. 345: SMASH Act S. 1213: Consumer Health Insurance Protection Act of 2019 Protecting Access to Medicare Act Gene Patients VALID - Verifying Accurate Leading Edge IVCT Development Prostate Cancer Misdiagnosis Elimination Act Eliminate Kickbacks in Recovery Act (EDRA) Resident Physician Shortage Reduction Act of 2019, S348, HR 1763

Client expense: $270,913 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor issues affecting the medical device industry, including S. 1379, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, as enacted, and the impact of natural disaster on saline supply.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises; H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548).

Client expense: $261,713 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Vice President of the U.S., White House Office

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548).

Client expense: $261,713 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Vice President of the U.S., White House Office

H.R.3 - Lower Drug Costs Now Act of 2019 S.977 - Transparent Drug Pricing Act of 2019 S.551, REFUND Act of 2019 H.R. 1520, the Purple Book Continuity Act H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act H.R. 965, the CREATES Act H.R.269/S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. S. 3013, Encouraging Innovative Benefit Design to Lowes Costs for Seniors Act S. 3129, Lower Cost, More Cures Act of 2019 H.R. 2296 - More Efficient Tools to Realize Information for Consumers Act H.R. 5741- Strengthening Innovation in Medicare and Medicaid Act - Issues related to Medicare and Medicaid coverage and reimbursement - Issues related to the 340B Drug Discount Program - Issues related to drug pricing - Medicare reimbursement for biosimilars - MACRA treatment and reimbursement of Part B drugs - Medicare payments for inpatient antimicrobials - Issues related to drug importation - Issues related to the International Pricing Index for Medicare Part B - Issues related to CMMI

Client expense: $2,710,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act - provisions related to infusion issues for Medicare patients, amendments to the Tax Cuts and Jobs Act (TCJA) and the orphan drug tax credit; Issues related to the use of plasma therapies in COVID-19 patients; S. 1379, H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 - provisions related to reauthorization of the Pandemic and All-Hazards Preparedness Act; Discussions to clarify or reform the 340B program; Discussions on value-based drug contracting; Proposals related to drug pricing, including House and Senate draft bills; S. 61, H.R. 478, The Safe and Affordable Drugs from Canada Act 0f 2019 - provisions related to importation; H.R. 465, S. 102, The Prescription Drug Price Relief Act of 2019 - provisions related to foreign reference pricing, patents and march-in rights; S. 97, H.R. 447, The Affordable and Safe Prescription Drug Importation Act - provisions related to importation; S. 205, The Right Rebate Act of 2019 -provisions related to Medicaid drug rebates and drug classification; The Patient Affordability, Value and Efficiency Act (not yet introduced); S. 378, H.R. 1093, The Stop Price Gouging Act - provisions related to prescription drug pricing; S. 657, Drug Price Transparency Act - provisions related to prescription drug pricing transparency and commercial market rebates; S. 844, Short on Competition Act - provisions related to the importation of prescription drugs; H.R. 2279, S. 2546, Safe Step Act - provisions related to step therapy policy; Discussions related to amending P.L. 97-414, Orphan Drug Act; H.R. 2375, S. 64, Preserve Access to Affordable Generics and Biosimilars Act - provisions related to patent settlements; H.R. 937, Right Rebate Act of 2019 - provisions related to Medicaid drug rebates and drug classification; H.R. 3276, S. 1785, Fair AMP Act - provisions related to AMP cap, exclusion of authorized generics from AMP; H.R. 3, Lower Drug Costs Now Act of 2019 - provisions related to the establishment of programs and requirements relating to the prices of prescription drugs; S. 2675 STOP Neglected Diseases of Poverty Act - provisions related to Dengue; Advisory Committee on Heritable Disorders in Newborns and Children - issues related to newborn screening; H.R. 4712, Fairness in Orphan Drug Exclusivity Act - provisions related to amending P.L. 97-414, Orphan Drug Act;

Client expense: $940,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 269/S. 1379). NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 269/S. 1379). NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 269/S. 1379). NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1423 / S. 610 - Forced Arbitration Injustice Repeal (FAIR) Act - oppose H.R. 5216 / S. 2943 - Quality Care for Nursing Home Residents Act - oppose H.R. 5326 - Fairness in Nursing Home Arbitration Act - oppose H.R. 2749 / S. 1491 - Restoring Justice for Workers Act - oppose S. 630 - Arbitration Fairness for Consumers Act - oppose S. 620 - Safety Over Arbitration Act - oppose S. 2627 - End Double Taxation of Successful Civil Claims Act- oppose H.R. 4982 - Health Care Workforce Protection Act - support H.R. 269 / S. 1379 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Pub. Law No. 116-22) - support S. 766 - PROTECT Asbestos Victims Act - support S. 471 - Litigation Funding Transparency Act - support

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

340B Drug Discount Program ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Antibiotic & Diagnostic Tax Credit Biodefense Research, Development and Procurement Issues (Non-funding) ---Executive Order on Modernizing Influenza Vaccines ---Gene Editing ---H.R.269/S.1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 ---Implementation of Medical Countermeasures Innovation Act ---Implementation of the 21st Century Cures Act of 2016 ---Implementation of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI) of 2019 ---National Biodefense Strategy ---Pandemic Influenza Preparedness ---Tropical Disease Priority Review Voucher (PRV) Program Biosimilars ---Access to Samples for Testing ---Biosimilar Copay Elimination ---Brazil Biologics Regulations ---Canada Biologics Regulations ---Coding ---H.R.965/S.340: CREATES Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---Implementation and Reauthorization of the Biosimilar User Fee Act of 2017 ---India Biologics Regulations ---Interchangeability and Pharmacy Substitution ---Mexico Biologics Regulations ---Naming ---Reimbursement ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 Climate Change ---RFI from House Select Committee on the Climate Crisis Comparative Effectiveness Research Initiatives ---Reauthorization of Patient-Centered Outcomes Research Institute 21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee Diagnostics and Personalized Medicine Regulation and Oversight ---VALID Act (Discussion Draft House) Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---FDA Review of CBD-Based Drugs ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI ---Innovation Incentives ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---Regulatory Reform & Modernization ---S.660: Efficiency and Transparency in Petitions Act ---Use of Real-World Evidence Drug Importation ---General ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---S.Con.Res25: The FY 2018 Budget Resolution Drug Patenting ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous (FLAT) Prices Act ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.1865: Minibus which consists of the Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development appropriations bills ---H.R.3199 Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---H.R.4398/S.1416: Affordable Prescriptions for Patients Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 ---S.1416: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 Drug Pricing ---CMMI Authority ---General ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.275: Medicare Prescription Drug Price Negotiation Act of 2019 ---H.R.488/S.99: Medicare Drug Price Negotiation Act of 2019 ---H.R.965/S.340: CREATES Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1093/S.378: Stop Price Gouging Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous Prices (FLAT) Prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.1865: Minibus which consists of the Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development appropriations bills ---H.R.2069/S.474: Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 ---H.R.2113: Prescription Drug STAR Act of 2019 ---H.R.2376/S.1227: Prescription Pricing for the People Act of 2019 ---H.R.2387: STOP GAMES Act of 2019 ---H.R.3199 Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---H.R.4398/S.1416: Affordable Prescriptions for Patients Act of 2019 ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---International Pricing Index Proposal ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) ---Pricing Transparency ---S.62: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.97: Affordable and Safe Prescription Drug Importation Act of 2019 ---S.476: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019 ---S.771: Improving Access to Affordable Prescription Drugs Act of 2019 ---S.844: Short on Competition Act of 2019 ---S.1416: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---S.2911:Seniors Prescription Drug Relief Act of 2019 Funding for Antimicrobial Resistance Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) Funding for FDA ---Aderholt Full Committee Amendment on Germline Editing ---Biotechnology and Agriculture Trade Program ---H.R.1158: Minibus which consists of FY 2020 Commerce-Justice-Science, Agriculture-Rural Development-FDA, Interior-Environment, Military Construction-Veterans Affairs, and Transportation-Housing and Urban Development appropriations bills ---H.R.3164/S.2522: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2020 Funding for Health Resources and Services Administration (HRSA) ---H.R.1865: Minibus which consists of the Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development appropriations bills ---Vaccine Injury Compensation Program (VICP) Funding for National Institutes of Health ---H.R.1865: Minibus which consists of the Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development appropriations bills ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.1865: Minibus which consists of the Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development appropriations bills Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---H.R.297: Increasing Competition in Pharmaceuticals Act of 2019 ---H.R.749: Lower Drug Costs Through Competition Act of 2018 ---H.R.938: Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 ---H.R.965/S.340: CREATES Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.2374/S.1224: Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act of 2019 ---Incentives for Generic Drug Entry ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.660: Efficiency and Transparency in Petitions Act International Biosecurity Policies Medicaid ---Alternative payment arrangements for gene therapies ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---S.3013: Encouraging Innovative Benefit Design to Lower Costs for Seniors Act Orphan Drug Issues ---Tax Credit Reimbursement and Coverage of Innovative Products ---Administration Rebate Rule ---CMMI Authority ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.488/S.99: Medicare Drug Price Negotiation Act of 2019 ---International Pricing Index Proposal ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Step Therapy ---Value-based Contracting and Communications The United States-Mexico-Canada Agreement ---IP Provisions US-China Trade Negotiations ---IP Provisions US-Japan Trade Agreement ---IP Provisions Vaccines and Infectious Diseases ---Executive Order on Modernizing Influenza Vaccines ---H.R.1973/S.1654: Vaccine Access Improvement Act of 2019 ---S.1872: Protecting Seniors through Immunizations Act of 2019 ---Vaccine and Anti-Microbial Resistance Product Development and Incentives

Client expense: $3,120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Biodefense Research, Development and Procurement Issues (Non-funding) ---Executive Order on Modernizing Influenza Vaccines ---Gene Editing ---H.R.269/S.1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 ---Implementation of Medical Countermeasures Innovation Act ---Implementation of the 21st Century Cures Act of 2016 ---Implementation of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI) of 2019 ---National Biodefense Strategy ---Pandemic Influenza Preparedness ---Tropical Disease Priority Review Voucher (PRV) Program Funding for Antimicrobial Resistance Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2020 (Discussion Draft Senate) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills)

Client expense: $3,120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Biodefense Research, Development and Procurement Issues (Non-funding) ---Executive Order on Modernizing Influenza Vaccines ---Gene Editing ---H.R.269/S.1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 ---Implementation of Medical Countermeasures Innovation Act ---Implementation of the 21st Century Cures Act of 2016 ---Implementation of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI) of 2019 ---National Biodefense Strategy ---Pandemic Influenza Preparedness ---Tropical Disease Priority Review Voucher (PRV) Program Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills) Funding for National Institutes of Health ---H.R.2740: Consolidated Appropriations Act of 2019 (which consists of the FY 2020 Labor-Health and Human Services-Education, Defense, State-Foreign Operations, and Energy-Water Development Appropriations Bills)

Client expense: $3,120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Repeal of the Affordable Care Act Development of legislation to protect essential hospitals Issues related to telehealth Mental Health Essential Health Benefits created by the Affordable Care Act Access to hospital emergency services Issues related to the 340B Drug Pricing Program ACA Cost Sharing Reduction Subsidies 340B dug pricing program CMS OPPS 340B rule moratorium-related legislation 42 CFR Part 2 IMD Exclusion Prescription drug monitoring programs Poison Center Network Enhancement Act A Bill to support the peer support specialist workforce CREATES Act-H.R. 965 The Advancing Care for Exceptional (ACE) Kids Act-H.R. 1226/S. 317 Cassidy Surprise Billing Draft Protecting Patients from Surprise Medical Bills Excellence in Metal Health Act (S. 824/H.R. 1767) Pandemic and All-Hazards Preparedness and Advancing Innovation Act (H.R. 269/S.1379) Patient Centered Outcomes Research Institute Funding No Surprises Act Lower Health Care Costs Act

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R.3 - Lower Drug Costs Now Act of 2019 S.977 - Transparent Drug Pricing Act of 2019 S.551, REFUND Act of 2019 H.R. 1520, the Purple Book Continuity Act H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act H.R. 965, the CREATES Act H.R.269/S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. S.3013, Encourging Innovative Benefti Design to Lowes Costs for Seniors Act S. 3129, Lower Cost, More Cures Act of 2019 - Issues related to Medicare and Medicaid coverage and reimbursement - Issues related to the 340B Drug Discount Program - Issues related to drug pricing - Medicare reimbursement for biosimilars - MACRA treatment and reimbursement of Part B drugs - Medicare payments for inpatient antimicrobials - Issues related to drug importation - Issues related to the International Pricing Index for Medicare Part B

Client expense: $1,580,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R.3 - Lower Drug Costs Now Act of 2019 Prescription Drug Pricing Reduction Act (PDPRA) of 2019 S.977 - Transparent Drug Pricing Act of 2019 H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities Act (340B PAUSE Act) S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 Part D Medicare Program (including Coverage Gap and other offsets in H.R.1892/P.L.115-123, Bipartisan Budget Act of 2018). HR 4392 - reversing the HOPPS rule reimbursement cut to 340B hospitals HR 5598 - 340B Optimization Act HR 2889 - Closing Loopholes for Orphan Drugs Act HR 6071 - SERV Communities Act HR 6240 - Drug Discount Accountability Act (user fees) S.3787 - DISARM Act of 2018 H.R. 7077, the Restoring the Patients Voice Act S.551, REFUND Act of 2019 H.R. 1520, the Purple Book Continuity Act H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act H.R. 965, the CREATES Act H.R.269/S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. -Issues related to Medicare and Medicaid coverage and reimbursement -Issues related to the 340B Drug Discount Program -Issues related to drug pricing -Medicare reimbursement for biosimilars -MACRA treatment and reimbursement of Part B drugs -Medicare payments for inpatient antimicrobials -Issues related to drug importation

Client expense: $2,620,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

S.977 - Transparent Drug Pricing Act of 2019 H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities Act (340B PAUSE Act) S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 Part D Medicare Program (including Coverage Gap and other offsets in H.R.1892/P.L.115-123, Bipartisan Budget Act of 2018). HR 4392 - reversing the HOPPS rule reimbursement cut to 340B hospitals HR 5598 - 340B Optimization Act HR 2889 - Closing Loopholes for Orphan Drugs Act HR 6071 - SERV Communities Act HR 6240 - Drug Discount Accountability Act (user fees) S.3787 - DISARM Act of 2018 H.R. 7077, the Restoring the Patients Voice Act S.551, REFUND Act of 2019 H.R. 1520, the Purple Book Continuity Act H.R. 1503, the Orange Book Transparency Act; H.R. 1499, the Protecting Consumer Access to Generic Drugs Act H.R. 965, the CREATES Act H.R.269/S.1379, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.1895, Lower Health Care Costs Act of 2019. - Issues related to Medicare and Medicaid coverage and reimbursement - Issues related to the 340B Drug Discount Program - Issues related to drug pricing - Medicare reimbursement for biosimilars - MACRA treatment and reimbursement of Part B drugs - Medicare payments for inpatient antimicrobials - Issues related to drug importation - Issues related to the International Pricing Index for Medicare Part D

Client expense: $1,620,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 269/S. 1379). NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 269/S. 1379). NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 269/S. 1379). NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 6.Implementation of Every Student Succeeds Act (Public Law 114-95) 7.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 8.FY 2020 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (H.R. 2740/Not Yet Introduced)) 9.FY 2020 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (H.R. 3164/Not yet introduced) 10.FY2020 Departments of Transportation, HUD and related agencies Appropriations (H.R. 3163/Not Yet Introduced) 11.FY2020 Further Consolidated Appropriations Act (H.R. 1865/P.L. 116-94) 12.Midnight Rules Relief Act (S.34/H.R. 21) 13.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 14.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 15.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 16.Regulatory Integrity Act (H.R. 1004) 17.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 18.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 19.American Health Care Act (H.R. 1628/H.Res. 228) 20.Ozone Standards Implementation Act (S. 263/H.R. 806) 21.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 22.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 23.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 24.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 25.Preventing Antibiotic Resistance Act (S. 629) 26.Better Care Reconciliation Act (H.R. 1628) and related amendments 27.Public Health Emergency Response Act (S. 196) 28.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 29.Consolidated Appropriations Act, 2017 (Public Law 115-31) 30.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 31.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 32.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 33.Tobacco Tax Equity Act (S. 1837) 34.Healthy Kids Act (S. 1821/H.R. 3921) 35.Implementation of the Drug Quality and Security Act (P.S. 113-54) 36.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 37.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 38.Lead-Safe Housing for Kids Act (S. 1845) 39.Supporting Working Moms Act (S. 2122/H.R. 3255) 40.Championing Healthy Kids Act (H.R. 3922) 41.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 42.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 43.Tax Cuts and Jobs Act (Public Law 115-97) 44.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 45.Vaccine Access Improvement Act (H.R. 4993) 46.Relief from New Source Performance Standards Act (H.R. 453) 47.Strategies to Address Antimicrobial Resistance (S. 2469) 48.Opioid Quota Reform Act (S. 2535) 49.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 50.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 51.Opioid Crisis Response Act of 2018 (S. 2680) 52.Agriculture and Nutrition Act (H.R. 2) 53.Agriculture Improvement Act (S. 3042) 54.SECURE Act (H.R. 5998) 55.Trauma-Informed Care for Children and Families Act (S. 774) 56.SUPPORT for Patients and Communities Act (H.R. 6) 57.Centers for Disease Control Emergency Response Act (S. 3161) 58.LABEL Opioids Act (S. 3428) 59.Relief from New Source Performance Standards Act (S. 1857) 60.Outdoors for All Act (S. 3499) 61.The MOMMA Act (H.R. 5977) 62.Preventing Maternal Deaths Act (H.R. 1318) 63.Medicare Access to Vaccines Equity Act (note yet introduced) 64.The Support Act (H.R. 6) 65.Climate Change Health Protection and Promotion Act (S. 529) 66.FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 3052/Not Yet Introduced) 67.NURSE Act (H.R. 1597) 68.Investing for the People Act (H.R. 2021) 69.Child Care for Working Families Act (H.R. 365/S. 568) 70.FAMILY Act (H.R. 1185/S. 463) 71.Transportation Alternatives Enhancement Act (S. 1098) 72.Lower Health Care Costs Act (S. 1895) 73.LIFT America Act (H.R 2479) 74.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 75.Older Americans Act reauthorization (not yet introduced) 76.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 77.Healthier Students for Stronger Campuses Act (S. 1281) 78.Saving Lives Through Better Data Act (S. 1793) 79.VACCINES Act (H.R. 2862) 80.DISARM Act (H.R. 4100/S. 1712) 81.Community Access, Resources, and Education for Families Act (H.R. 3117) 82.Protecting Seniors Through Immunization Act (S. 1872) 83.Tobacco-Free Youth Act (S. 1541) 84.Tobacco to 21 Act (H.R. 2411/S. 1258) 85.Investing for People Act (H.R. 2021) 86.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 87.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) 88.Social Determinants Accelerator Act (H.R. 4004) 89.Mental Health Professionals Workforce Shortage Loan Repayment Act (H.R. 2431) 90.The UNDERSTAND Act (S. 1323) 91.Americas Transportation Infrastructure Act (S. 2302) 92.Health Equity and Accountability Act (Not yet introduced) 93.Barriers to Suicide Act of 2019 (H.R. 4309) 94.Promoting Physical Activity for Americans Act (S. 1608) 95.Public Health Infrastructure Modernization Act of 2019 (H.R. 5321) 96.Supporting Healthy Mothers and Infants Act (H.R. 5249) 97.Lead-Free Future Act (H.R. 4416) 98.Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R. 4768) 99.Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide (H.Res. 592) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, NIMH, Education, USDA, DHS, FEMA, and SAMHSA.

Client expense: $35,486 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 7.Implementation of Every Student Succeeds Act (Public Law 114-95) 8.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 9.FY 2020 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (H.R. 2740/Not Yet Introduced)) 10.FY 2020 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (H.R. 3164/Not yet introduced) 11.FY2020 Departments of Transportation, HUD and related agencies Appropriations (H.R. 3163/Not Yet Introduced) 12.Midnight Rules Relief Act (S.34/H.R. 21) 13.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 14.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 15.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 16.Regulatory Integrity Act (H.R. 1004) 17.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 18.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 19.American Health Care Act (H.R. 1628/H.Res. 228) 20.Ozone Standards Implementation Act (S. 263/H.R. 806) 21.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 22.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 23.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 24.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 25.Preventing Antibiotic Resistance Act (S. 629) 26.Better Care Reconciliation Act (H.R. 1628) and related amendments 27.Public Health Emergency Response Act (S. 196) 28.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 29.Consolidated Appropriations Act, 2017 (Public Law 115-31) 30.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 31.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 32.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 33.Tobacco Tax Equity Act (S. 1837) 34.Healthy Kids Act (S. 1821/H.R. 3921) 35.Implementation of the Drug Quality and Security Act (P.S. 113-54) 36.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 37.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 38.Lead-Safe Housing for Kids Act (S. 1845) 39.Supporting Working Moms Act (S. 2122/H.R. 3255) 40.Championing Healthy Kids Act (H.R. 3922) 41.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 42.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 43.Tax Cuts and Jobs Act (Public Law 115-97) 44.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 45.Vaccine Access Improvement Act (H.R. 4993) 46.Relief from New Source Performance Standards Act (H.R. 453) 47.Strategies to Address Antimicrobial Resistance (S. 2469) 48.Opioid Quota Reform Act (S. 2535) 49.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 50.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 51.Health Equity and Accountability Act (H.R. 5942) 52.Opioid Crisis Response Act of 2018 (S. 2680) 53.Agriculture and Nutrition Act (H.R. 2) 54.Agriculture Improvement Act (S. 3042) 55.SECURE Act (H.R. 5998) 56.Trauma-Informed Care for Children and Families Act (S. 774) 57.SUPPORT for Patients and Communities Act (H.R. 6) 58.Centers for Disease Control Emergency Response Act (S. 3161) 59.LABEL Opioids Act (S. 3428) 60.Relief from New Source Performance Standards Act (S. 1857) 61.Outdoors for All Act (S. 3499) 62.The MOMMA Act (H.R. 5977) 63.Preventing Maternal Deaths Act (H.R. 1318) 64.Medicare Access to Vaccines Equity Act (note yet introduced) 65.The Support Act (H.R. 6) 66.Climate Change Health Protection and Promotion Act (S. 529) 67.FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 3052/Not Yet Introduced) 68.NURSE Act (H.R. 1597) 69.Investing for the People Act (H.R. 2021) 70.Child Care for Working Families Act (H.R. 365/S. 568) 71.FAMILY Act (H.R. 1185/S. 463) 72.Transportation Alternatives Enhancement Act (S. 1098) 73.Lower Health Care Costs Act (S. 1895) 74.LIFT America Act (H.R 2479) 75.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 76.Older Americans Act reauthorization (not yet introduced) 77.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 78.Healthier Students for Stronger Campuses Act (S. 1281) 79.Saving Lives Through Better Data Act (S. 1793) 80.VACCINES Act (H.R. 2862) 81.DISARM Act (S. 1712/not yet introduced) 82.Community Access, Resources, and Education for Families Act (H.R. 3117) 83.Protecting Seniors Through Immunization Act (S. 1872) 84.Tobacco-Free Youth Act (S. 1541) 85.Tobacco to 21 Act (H.R. 2411/S. 1258) 86.Investing for People Act (H.R. 2021) 87.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 88.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

Client expense: $40,118 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)

Monitor issues affecting the medical device industry, including S. 1379, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, as enacted, the medical device tax, and the impact of natural disaster on saline supply.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE